All Stories

  1. Bedaquiline and Delamanid Combination Treatment of 5 Patients with Pulmonary Extensively Drug-Resistant Tuberculosis

    Article • Emerging Infectious Diseases, October 2017, Centers for Disease Control and Prevention (CDC)

    Dr Andrei, Andrey Mariandyshev, Maryandyshev

  2. What happened to patients with RMP-resistant/MDR-TB in Zambia reported as lost to follow-up from 2011 to 2014?

    Article • The International Journal of Tuberculosis and Lung Disease, August 2017, International Union Against Tuberculosis and Lung Disease

    Dr Andrei, Andrey Mariandyshev, Maryandyshev

  3. Drug-resistant tuberculosis threatens WHO's End-TB strategy

    Article • The Lancet Infectious Diseases, July 2017, Elsevier

    Dr Andrei, Andrey Mariandyshev, Maryandyshev

  4. Effectiveness and safety of bedaquiline-containing regimens in the treatment of MDR- and XDR-TB: a multicentre study

    Article • European Respiratory Journal, May 2017, European Respiratory Society (ERS)

    Dr Andrei, Andrey Mariandyshev, Maryandyshev, MD, PhD Jerker Jonsson

  5. Multidrug-resistant tuberculosis in children in northwest Russia: an observational cohort study

    Article • European Respiratory Journal, September 2016, European Respiratory Society (ERS)

    Dr Andrei, Andrey Mariandyshev, Maryandyshev

  6. Outbreak of tuberculosis in a closed setting: views on transmission based on results from molecular and conventional methods

    Article • Journal of Hospital Infection, June 2016, Elsevier

    Dr Andrei, Andrey Mariandyshev, Maryandyshev

  7. The Impact of a Line Probe Assay Based Diagnostic Algorithm on Time to Treatment Initiation and Treatment Outcomes for Multidrug Resistant TB Patients in Arkhangelsk Region, Russia

    Article • PLoS ONE, April 2016, PLOS

    Dr Andrei, Andrey Mariandyshev, Maryandyshev

  8. Descriptive review of tuberculosis surveillance systems across the circumpolar regions

    Article • International Journal of Circumpolar Health, January 2016, Taylor & Francis

    Dr Andrei, Andrey Mariandyshev, Maryandyshev, MD, PhD Jerker Jonsson

  9. Bedaquiline in the treatment of multidrug- and extensively drug-resistant tuberculosis

    Article • European Respiratory Journal, December 2015, European Respiratory Society (ERS)

    Dr Andrei, Andrey Mariandyshev, Maryandyshev

  10. Risk Factors for Acquisition of Drug Resistance during Multidrug-Resistant Tuberculosis Treatment, Arkhangelsk Oblast, Russia, 2005–2010

    Article • Emerging Infectious Diseases, June 2015, Centers for Disease Control and Prevention (CDC)

    Dr Andrei, Andrey Mariandyshev, Maryandyshev

  11. Tuberculosis in BRICS: challenges and opportunities for leadership within the post-2015 agenda

    Article • Bulletin of the World Health Organization, June 2014, WHO Press

    Dr Andrei, Andrey Mariandyshev, Maryandyshev

  12. A comparison between passive and active case finding in TB control in the Arkhangelsk region

    Article • International Journal of Circumpolar Health, January 2014, Taylor & Francis

    Dr Andrei, Andrey Mariandyshev, Maryandyshev

  13. Two vicious circles contributing to a diagnostic delay for tuberculosis patients in Arkhangelsk

    Article • Emerging Health Threats Journal, January 2014, Taylor & Francis

    Dr Andrei, Andrey Mariandyshev, Maryandyshev

  14. Hopelessness as a basis for tuberculosis diagnostic delay in the Arkhangelsk region: a grounded theory study

    Article • BMC Public Health, August 2013, Springer Science + Business Media

    Dr Andrei, Andrey Mariandyshev, Maryandyshev

  15. Epidemiological analyses of tuberculosis in Archangelsk, Russia and implementation of a rapid assay for detection of resistance in this high burden setting

    Article • International Journal of Mycobacteriology, June 2013, Medknow

    Dr Andrei, Andrey Mariandyshev, Maryandyshev

  16. Incidence of Tuberculosis and Associations with Indicators of Alcohol Consumption in Three Regions of Northwest Russia in 1975–2009: A Time-Series Analysis

    Article • Journal of Environmental and Public Health, January 2013, Hindawi Publishing Corporation

    Dr Andrei, Andrey Mariandyshev, Maryandyshev

  17. WHO guidelines for the programmatic management of drug-resistant tuberculosis: 2011 update

    Article • European Respiratory Journal, August 2011, European Respiratory Society (ERS)

    Dr Andrei, Andrey Mariandyshev, Maryandyshev

  18. Fluoroquinolones: are they essential to treat multidrug-resistant tuberculosis?

    Article • European Respiratory Journal, April 2008, European Respiratory Society (ERS)

    Dr Andrei, Andrey Mariandyshev, Maryandyshev, Dr Giovanni Ferrara

  19. Resistance to second-line injectables and treatment outcomes in multidrug-resistant and extensively drug-resistant tuberculosis cases

    Article • European Respiratory Journal, March 2008, European Respiratory Society (ERS)

    Dr Andrei, Andrey Mariandyshev, Maryandyshev, Dr Giovanni Ferrara

  20. P1643 Comparison of quality of drug susceptibility testing of Mycobacterium tuberculosis by absolute concentration method and BACTEC 460

    Article • International Journal of Antimicrobial Agents, March 2007, Elsevier

    Dr Andrei, Andrey Mariandyshev, Maryandyshev

  21. Resistance of multidrug-resistant strains of Mycobacterium tuberculosis from the Archangel oblast, Russia, to second-line anti-tuberculosis drugs

    Article • European Journal of Clinical Microbiology & Infectious Diseases, March 2005, Springer Science + Business Media

    Dr Andrei, Andrey Mariandyshev, Maryandyshev

  22. Impact of drug resistance on fitness of Mycobacterium tuberculosis strains of the W-Beijing genotype

    Article • FEMS Immunology & Medical Microbiology, November 2004, Oxford University Press (OUP)

    Dr Andrei, Andrey Mariandyshev, Maryandyshev

  23. Impact of Drug-Resistant Mycobacterium tuberculosis on Treatment Outcome of Culture-Positive Cases of Tuberculosis in the Archangel Oblast, Russia, in 1999

    Article • European Journal of Clinical Microbiology & Infectious Diseases, March 2004, Springer Science + Business Media

    Dr Andrei, Andrey Mariandyshev, Maryandyshev

  24. Molecular Epidemiology and Drug Resistance of Mycobacterium tuberculosis Isolates in the Archangel Prison in Russia: Predominance of the W-Beijing Clone Family

    Article • Clinical Infectious Diseases, September 2003, Oxford University Press (OUP)

    Dr Andrei, Andrey Mariandyshev, Maryandyshev

  25. Spread of Drug-Resistant Mycobacterium tuberculosis Strains of the Beijing Genotype in the Archangel Oblast, Russia

    Article • Journal of Clinical Microbiology, June 2002, ASM Journals

    Dr Andrei, Andrey Mariandyshev, Maryandyshev